Tailoring polymeric micelles for improved olaparib solubility and drug release

FHS
May 23, 2024
8:24 pm

Olaparib is a selective poly (ADP-ribose) polymerase inhibitor. However, its clinical application is hindered by low solubility and undesired pharmacokinetic profiles (e.g., relatively short circulation).

New study highlights paternal influence on child’s T1D risk

New research to be presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) (Madrid, 9-13 September) shows that

July 27, 2024

Vivalink Unveils Biometrics Data Platform for Remote Hospital-at-Home Monitoring

What You Should Know: – Vivalink, a leader in digital healthcare solutions, is transforming patient care with its Biometrics Data Platform. – Vivalink’s Biometrics Data

March 13, 2024

Indoor Air Purification Improved Pulmonary Health in Kids

Indoor air purification improved pulmonary health markers among children living in a region with severe air pollution, a cluster randomized trial showed. Among 79 kids

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.